Market Tracker

10/18 5:16pm ET

ImmuCell Corp (NASDAQ:ICCC)

7.59
Delayed Data
As of Oct 18
 0.00 / 0.00%
Today’s Change
4.76
Today|||52-Week Range
7.98
+27.56%
Year-to-Date
No recent news for ImmuCell Corp.

Today’s Trading

Previous close7.59
Today’s open7.65
Day’s range7.26 - 7.70
Volume11,120
Average volume (3 months)10,088
Market cap$38.3M
Dividend yield--
Data as of 3:56pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)-68.42%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-6.69%
P/E ratio94.9
Price/Sales2.70
Price/Book1.87

Competitors

 Today’s
change
Today’s
% change
CRMDCorMedix Inc+0.03+5.84%
APVOAptevo Therapeutics ...-0.09-3.73%
BPTHBio Path Holdings In...-0.01-1.33%
CSBRChampions Oncology I...+0.03+0.95%
Data as of 7:59pm ET, 10/18/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$9.5M
Annual profit (last year)$508.4K
Net profit margin5.33%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, CEO, Secretary, Treasurer &
Director
Michael F. Brigham
Director &
Chief Scientific Officer
Joseph H. Crabb
Corporate headquarters
Portland, Maine

Forecasts